Researchers found that alterations in the gut microbiome that are linked to graft-versus-host disease severity are connected to an increase in oxygen levels in the intestine that follows immune-mediated intestinal damage. Pharmacologically reducing intestinal oxygen levels alleviated the microbial imbalance and reduced the severity of the condition in animal models.